Advertisement
Person › Details
Detlev Mennerich (Boehringer Ingelheim Venture Fund (BIVF))
Mennerich, Detlev (Boehringer Ingelheim 201604 Investment Manager at BIVF)
Organisation | Boehringer Ingelheim Venture Fund (BIVF) | |
Group | Boehringer Ingelheim (Group) | |
Product | venture capital | |
Product 2 | LIFE SCIENCES | |
Record changed: 2021-09-19 |
Advertisement
More documents for Detlev Mennerich
- [1] Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield....
- [2] Topas Therapeutics GmbH. (11/2/17). "Press Release: Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund". Hamburg....
- [3] HepaRegenix GmbH. (1/5/17). "Press Release: HepaRegenix GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases". Tübingen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top